Six integrated platforms. One global compliance framework. A team of 30+ PhD scientists operating the wet-lab, the in vivo facility, and the AI stack under a single roof.
Fully automated, miniaturized screening workflows that interrogate up to 500K compounds per week against your target of interest.
Atomic-resolution structure determination to support structure-based design and mechanism-of-action studies.
Regulatory-grade rigor baked into every study — from preclinical toxicology to CMC-ready analytical method development.
AAALAC-accredited vivarium with rodent and non-rodent models, surgical capabilities, and integrated PK/PD readouts.
End-to-end multi-omics: bulk & single-cell NGS, spatial transcriptomics, and high-resolution proteomics.
AlphaFold-class structure prediction, generative chemistry, and ML-driven target identification — run by PhD scientists.
We routinely design bespoke workflows for novel modalities and emerging target classes.
Request a Platform Tour